Biochemical markers of myocardial remodelling in hypertensive heart disease.
about
Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failureMyocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study.Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts.TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death.Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study.Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis.Expression patterns of sarcomeric α-actin, α-actinin and UCP2 in the myocardium of Kunming mice after exposure to c-terminal polypeptide of cardiotrophin-1.
P2860
Q30477731-E2571C5C-5D6D-41CC-9260-993BAF022DEEQ33810217-6ECB784C-605A-47C5-8301-D39E93CF3CD5Q34629550-DD269ACA-2E21-4C98-B9E6-00A8E4018B83Q35777180-435B5118-FAE4-4C4E-A8E3-DE0C06185E27Q36253578-D1A98972-4D4B-4B5A-8C91-9EF93CAEBBF2Q37343367-E49A2CA9-14C6-426B-913A-00B86D765301Q42362900-6315FC68-A76E-4377-BC47-77000B9C7A42Q43293197-A62A07F5-D55D-4E0F-8F23-0B0EC1F9E75EQ47265220-589901E8-FA84-43CF-8082-4C0146D2270BQ47392248-0AA20E09-F5EF-42FC-A2AA-23361737B838Q53580573-84DF7573-9663-4A51-83CB-508393952843Q53669329-D5DD1508-12B4-4F51-8071-0536721F9F4E
P2860
Biochemical markers of myocardial remodelling in hypertensive heart disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biochemical markers of myocardial remodelling in hypertensive heart disease.
@en
Biochemical markers of myocardial remodelling in hypertensive heart disease.
@nl
type
label
Biochemical markers of myocardial remodelling in hypertensive heart disease.
@en
Biochemical markers of myocardial remodelling in hypertensive heart disease.
@nl
prefLabel
Biochemical markers of myocardial remodelling in hypertensive heart disease.
@en
Biochemical markers of myocardial remodelling in hypertensive heart disease.
@nl
P2093
P2860
P356
P1476
Biochemical markers of myocardial remodelling in hypertensive heart disease.
@en
P2093
Amaia Zudaire
Arantxa González
Javier Beaumont
Javier Díez
Nerea Hermida
Teresa Arias
P2860
P304
P356
10.1093/CVR/CVN235
P577
2008-09-01T00:00:00Z